ZNF875
geneOn this page
Summary
ZNF875 (zinc finger protein 875, HGNC:4928) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 875 (P10072). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 284459 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 115 total
- MANE Select transcript:
NM_001353803
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4928 |
| Approved symbol | ZNF875 |
| Name | zinc finger protein 875 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000181666 |
| Ensembl biotype | protein_coding |
| OMIM | 165250 |
| Entrez | 284459 |
Gene structure
Transcript identifiers
Ensembl transcripts: 37 — 28 protein_coding, 5 protein_coding_CDS_not_defined, 3 retained_intron, 1 nonsense_mediated_decay
ENST00000324411, ENST00000392153, ENST00000541583, ENST00000544914, ENST00000585623, ENST00000586897, ENST00000587437, ENST00000587570, ENST00000587829, ENST00000588820, ENST00000589188, ENST00000589218, ENST00000589392, ENST00000589801, ENST00000590166, ENST00000590386, ENST00000590570, ENST00000590582, ENST00000591134, ENST00000591259, ENST00000591391, ENST00000591417, ENST00000591471, ENST00000591485, ENST00000592168, ENST00000592362, ENST00000592768, ENST00000652615, ENST00000862310, ENST00000862311, ENST00000862312, ENST00000862313, ENST00000862314, ENST00000862315, ENST00000911520, ENST00000970697, ENST00000970698
RefSeq mRNA: 22 — MANE Select: NM_001353803
NM_001329761, NM_001329762, NM_001329763, NM_001329764, NM_001329765, NM_001329766, NM_001329767, NM_001329768, NM_001329769, NM_001329770, NM_001329771, NM_001329772, NM_001329773, NM_001329774, NM_001329775, NM_001329776, NM_001329777, NM_001329778, NM_001329779, NM_001353803, NM_001353804, NM_181786
CCDS: CCDS12502, CCDS82337, CCDS82338, CCDS82339, CCDS86758
Canonical transcript exons
ENST00000392153 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001664741 | 37334649 | 37334782 |
| ENSE00002816417 | 37362109 | 37364447 |
| ENSE00003526968 | 37347190 | 37347316 |
| ENSE00003643497 | 37335169 | 37335257 |
| ENSE00003659035 | 37347777 | 37347872 |
Expression profiles
Bgee: expression breadth ubiquitous, 250 present calls, max score 98.45.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 19.9051 / max 252.0935, expressed in 1745 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175545 | 12.8719 | 1704 |
| 175547 | 6.7378 | 1582 |
| 175548 | 0.1178 | 60 |
| 175546 | 0.1165 | 44 |
| 175551 | 0.0552 | 6 |
| 175550 | 0.0059 | 3 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 98.45 | gold quality |
| endothelial cell | CL:0000115 | 96.41 | gold quality |
| right uterine tube | UBERON:0001302 | 95.68 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 95.54 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 95.31 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 95.19 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.19 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.11 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.10 | gold quality |
| thyroid gland | UBERON:0002046 | 94.86 | gold quality |
| pituitary gland | UBERON:0000007 | 94.60 | gold quality |
| apex of heart | UBERON:0002098 | 94.42 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.36 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.00 | gold quality |
| cerebellum | UBERON:0002037 | 93.95 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 93.74 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.47 | gold quality |
| left ovary | UBERON:0002119 | 93.47 | gold quality |
| right ovary | UBERON:0002118 | 93.22 | gold quality |
| metanephros cortex | UBERON:0010533 | 92.94 | gold quality |
| minor salivary gland | UBERON:0001830 | 92.80 | gold quality |
| primary visual cortex | UBERON:0002436 | 92.73 | gold quality |
| right testis | UBERON:0004534 | 92.65 | gold quality |
| left testis | UBERON:0004533 | 92.61 | gold quality |
| adrenal gland | UBERON:0002369 | 92.54 | gold quality |
| adrenal cortex | UBERON:0001235 | 92.52 | gold quality |
| endocervix | UBERON:0000458 | 92.28 | gold quality |
| body of uterus | UBERON:0009853 | 92.26 | gold quality |
| right atrium auricular region | UBERON:0006631 | 92.16 | gold quality |
| skin of abdomen | UBERON:0001416 | 92.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.27 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): STAT1
miRNA regulators (miRDB)
40 targeting ZNF875, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6499-3P | 99.90 | 66.38 | 1212 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-383-3P | 99.85 | 65.84 | 1359 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-6882-5P | 99.35 | 71.13 | 1206 |
| HSA-MIR-7515 | 99.31 | 68.22 | 1795 |
| HSA-MIR-4710 | 98.61 | 65.96 | 1048 |
| HSA-MIR-6852-3P | 98.54 | 67.60 | 1468 |
| HSA-MIR-3136-5P | 98.53 | 67.68 | 793 |
| HSA-MIR-4439 | 98.53 | 67.53 | 793 |
| HSA-MIR-6883-3P | 97.97 | 67.35 | 643 |
| HSA-MIR-3132 | 97.96 | 67.91 | 711 |
| HSA-MIR-4736 | 97.96 | 65.89 | 1287 |
| HSA-MIR-450B-3P | 97.56 | 66.12 | 512 |
| HSA-MIR-3909 | 97.55 | 66.78 | 887 |
Literature-anchored findings (GeneRIF, showing 2)
- Ahk1 is a scaffold protein in the HKR1 subbranch and prevents incorrect signal flow from Hkr1 to Kss1 (PMID:26787842)
- the methylation profile combination of HKR1, ROD1, and NLRC5 could be a promising biomarker for aging in Hainan centenarians (PMID:29394898)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 875 — P10072 (reviewed: P10072)
Alternative names: Krueppel-related zinc finger protein 1, Protein HKR1
All UniProt accessions (18): A0A1B0GXI2, A0A494C010, P10072, F5H6A5, K7EJS1, K7EL05, K7EL22, K7EL36, K7EM51, K7EME6, K7EMG8, K7EMJ9, K7ENA5, K7EPW3, K7EQG8, K7ERA5, K7ES32, Q7Z6E1
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P10072-1 | 1 | yes |
| P10072-2 | 2 |
RefSeq proteins (22): NP_001316690, NP_001316691, NP_001316692, NP_001316693, NP_001316694, NP_001316695, NP_001316696, NP_001316697, NP_001316698, NP_001316699, NP_001316700, NP_001316701, NP_001316702, NP_001316703, NP_001316704, NP_001316705, NP_001316706, NP_001316707, NP_001316708, NP_001340732, NP_001340733, NP_861451 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR048414 | PDRM9-like_Znf-C2H2 | Domain |
Pfam: PF00096, PF01352, PF21225
UniProt features (21 total): zinc finger region 13, sequence variant 3, chain 1, domain 1, region of interest 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P10072-F1 | 66.73 | 0.25 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 53 (showing top):
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, OSMAN_BLADDER_CANCER_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, HATADA_METHYLATED_IN_LUNG_CANCER_UP, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN, FIGUEROA_AML_METHYLATION_CLUSTER_1_UP, FIGUEROA_AML_METHYLATION_CLUSTER_3_UP, FIGUEROA_AML_METHYLATION_CLUSTER_4_UP, SNACANNNYSYAGA_UNKNOWN, ZWANG_DOWN_BY_2ND_EGF_PULSE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX5_TARGET_GENES, CEBPZ_TARGET_GENES, NPAT_TARGET_GENES, PRKDC_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), sequence-specific DNA binding (GO:0043565), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
302 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF875 | MYCL | P12524 | 498 |
| ZNF875 | OPN5 | Q6U736 | 458 |
| ZNF875 | MYCN | P04198 | 431 |
| ZNF875 | RHO | P08100 | 399 |
| ZNF875 | NRAS | P01111 | 390 |
| ZNF875 | PLEKHH3 | Q7Z736 | 353 |
| ZNF875 | OPN4 | Q9UHM6 | 324 |
| ZNF875 | ERBB2 | P04626 | 317 |
| ZNF875 | GTF2H2C | Q6P1K8 | 311 |
| ZNF875 | TCP10L | Q8TDR4 | 310 |
| ZNF875 | HEATR5B | Q9P2D3 | 305 |
| ZNF875 | APOE | P02649 | 305 |
| ZNF875 | EGFR | P00533 | 305 |
| ZNF875 | FAM110A | Q9BQ89 | 300 |
| ZNF875 | GPR135 | Q8IZ08 | 289 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC9A8 | AP1G1 | psi-mi:“MI:0914”(association) | 0.350 |
| CDK11A | PRPF40A | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (6): HKR1 (Affinity Capture-RNA), HKR1 (Affinity Capture-MS), HKR1 (Affinity Capture-MS), HKR1 (Affinity Capture-MS), HKR1 (Affinity Capture-RNA), HKR1 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
115 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 101 |
| Likely benign | 10 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1265 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:37344788:TGTTA:T | donor_gain | 1.0000 |
| 19:37344789:GTTAA:G | donor_gain | 1.0000 |
| 19:37344790:TTA:T | donor_gain | 1.0000 |
| 19:37347770:T:G | acceptor_gain | 1.0000 |
| 19:37334778:GTTCC:G | donor_gain | 0.9900 |
| 19:37334783:G:GG | donor_gain | 0.9900 |
| 19:37335255:GAG:G | donor_gain | 0.9900 |
| 19:37335255:GAGGT:G | donor_loss | 0.9900 |
| 19:37335257:GGTG:G | donor_loss | 0.9900 |
| 19:37335258:GTGAG:G | donor_loss | 0.9900 |
| 19:37335259:T:G | donor_loss | 0.9900 |
| 19:37344767:G:GT | donor_gain | 0.9900 |
| 19:37344932:A:AG | acceptor_gain | 0.9900 |
| 19:37344933:G:GG | acceptor_gain | 0.9900 |
| 19:37347769:A:AG | acceptor_gain | 0.9900 |
| 19:37347769:AT:A | acceptor_gain | 0.9900 |
| 19:37347770:T:TA | acceptor_gain | 0.9900 |
| 19:37347775:A:AG | acceptor_gain | 0.9900 |
| 19:37347776:G:GG | acceptor_gain | 0.9900 |
| 19:37347776:GAA:G | acceptor_gain | 0.9900 |
| 19:37347869:CCAGG:C | donor_loss | 0.9900 |
| 19:37347870:CAGG:C | donor_loss | 0.9900 |
| 19:37347874:T:A | donor_loss | 0.9900 |
| 19:37344745:A:AG | donor_gain | 0.9800 |
| 19:37344745:A:G | donor_gain | 0.9800 |
| 19:37344768:A:T | donor_gain | 0.9800 |
| 19:37345022:G:GG | donor_gain | 0.9800 |
| 19:37347774:CA:C | acceptor_loss | 0.9800 |
| 19:37347775:AGAA:A | acceptor_loss | 0.9800 |
| 19:37347776:G:GT | acceptor_loss | 0.9800 |
AlphaMissense
4195 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:37362723:T:C | F310L | 0.999 |
| 19:37362725:T:A | F310L | 0.999 |
| 19:37362725:T:G | F310L | 0.999 |
| 19:37362807:T:C | F338L | 0.999 |
| 19:37362809:T:A | F338L | 0.999 |
| 19:37362809:T:G | F338L | 0.999 |
| 19:37362910:T:C | L372P | 0.999 |
| 19:37362975:T:C | F394L | 0.999 |
| 19:37362977:T:A | F394L | 0.999 |
| 19:37362977:T:G | F394L | 0.999 |
| 19:37363059:T:C | F422L | 0.999 |
| 19:37363061:T:A | F422L | 0.999 |
| 19:37363061:T:G | F422L | 0.999 |
| 19:37363078:T:C | L428P | 0.999 |
| 19:37363311:T:C | F506L | 0.999 |
| 19:37363313:T:A | F506L | 0.999 |
| 19:37363313:T:G | F506L | 0.999 |
| 19:37362976:T:C | F394S | 0.998 |
| 19:37363060:T:C | F422S | 0.998 |
| 19:37363088:C:A | H431Q | 0.998 |
| 19:37363088:C:G | H431Q | 0.998 |
| 19:37363143:T:C | F450L | 0.998 |
| 19:37363145:T:A | F450L | 0.998 |
| 19:37363145:T:G | F450L | 0.998 |
| 19:37363395:T:C | F534L | 0.998 |
| 19:37363397:T:A | F534L | 0.998 |
| 19:37363397:T:G | F534L | 0.998 |
| 19:37362742:T:C | L316P | 0.997 |
| 19:37362891:T:C | F366L | 0.997 |
| 19:37362893:T:A | F366L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000052138 (19:37336560 A>G), RS1000110173 (19:37338279 C>G,T), RS1000212088 (19:37353030 C>T), RS1000225887 (19:37338045 T>A), RS1000249682 (19:37343586 T>C), RS1000287857 (19:37335126 G>A,C,T), RS1000304727 (19:37350468 C>T), RS1000368159 (19:37350236 C>G,T), RS1000544560 (19:37330387 C>G,T), RS1000604727 (19:37344910 C>A), RS1000795873 (19:37324988 C>T), RS1000825677 (19:37324794 A>G), RS1000942193 (19:37318788 A>G,T), RS1000954653 (19:37351349 T>C), RS1001000373 (19:37356705 C>A)
Disease associations
OMIM: gene MIM:165250 | disease phenotypes: MIM:617468, MIM:208150
GenCC curated gene-disease
Mondo (2): arthrogryposis multiplex congenita (MONDO:0015168), fetal akinesia deformation sequence 1 (MONDO:0100101)
Orphanet (2): Arthrogryposis multiplex congenita (Orphanet:1037), Fetal akinesia deformation sequence (Orphanet:994)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, increases methylation | 3 |
| bisphenol A | affects cotreatment, decreases expression, increases methylation | 2 |
| FR900359 | increases phosphorylation | 1 |
| bisphenol F | affects cotreatment, decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | increases expression, increases response to substance | 1 |
| Bortezomib | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Arsenic | increases methylation | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Quercetin | increases expression | 1 |
| Urethane | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
4 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT05393375 | Not specified | COMPLETED | Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional Evaluation |
| NCT05673265 | Not specified | UNKNOWN | Pediatric and Adult Registry for Patients With ARThrogryposis |
| NCT06130592 | Not specified | UNKNOWN | Technical Feasibility Study of Ultrasound Muscle Imaging in Antenatal Ultrasound |
| NCT07360574 | Not specified | NOT_YET_RECRUITING | Piezo2-related Arthrogryposis & physiopathOLOgy 3 |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): arthrogryposis multiplex congenita, fetal akinesia deformation sequence 1